Reactive Balance Training with Augmented Reality for Older Adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, single-blinded trial, 36 community-dwelling adults aged 60 and older at increased fall risk will be assigned to either reactive balance training with augmented reality (RBT+AR) or treadmill walking without AR. The RBT+AR group will complete two treadmill sessions that simulate tripping and slipping with AR headsets, while the control group does two treadmill walking sessions without perturbations or AR. Researchers will compare changes in postural stability, mobility, strength, balance performance, quality of life, balance confidence, muscle activation, and executive function before and after training, and again four months later for retention. Falls will be tracked for 12 months after training to assess long-term impact. The study is conducted under single-blind conditions and will analyze between-group differences to identify training-induced effects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Community-dwelling adults aged 60 years old or older
* Able to communicate effectively in Cantonese or Mandarin
* Able to walk independently on level ground for at least 30 minutes
* Abbreviated Mental Test (Hong Kong version) scores \> 6
* Have fallen in the preceding year, have concerns about falling, or feel unsteady while walking or standing.

Exclusion Criteria:

* Uncorrected vision or hearing impairment
* Osteoporosis
* Have a history of hip or knee replacement
* Resting blood pressure ≥ 160/100 mmHg
* Resting heart rate exceeds the 60-100 beat/min normal range
* Have musculoskeletal conditions causing pain or functional limitation that would preclude safe performance of study procedures (e.g., acute fracture)
* Have cardiovascular conditions that may pose risks during training or assessment (e.g., uncontrolled arrhythmias)
* Have mental health conditions impairing decision-making capacity or ability to comply with study instructions (e.g., psychosis)
* Have neurological conditions affecting balance, coordination in a way that would increase safety risk (e.g., Parkinson's disease)
* Participating or planning to participate in another fall prevention program.

Where it's running

• The Hong Kong Polytechnic University
  Hong Kong, Hong Kong Recruiting

Study contacts

• Study coordinator: Sau Lan Tsang, PhD
• Email: charlotte-sl.tsang@polyu.edu.hk
• Phone: +852 3400 8965

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Bioequivalence comparison between YHP2508B and YHR2602 in healthy adults

  This study tests whether YHP2508B and YHR2602 deliver similar amounts of the drug in healthy adults after a single dose.

  Recruiting Phase 1 Yuhan Corporation · Gimpo-si · NCT07912840

• Bioequivalence test of two drugs in healthy adults

  This study tests whether YHP2508A and YHR2601 are bioequivalent in healthy volunteers.

  Recruiting at 2 sites Phase 1 Yuhan Corporation · Seoul and 1 other locations · NCT07912827

• How the body responds to exercise with low oxygen in healthy adults

  Researchers test how healthy men and women respond to different exercise types while breathing air with varying oxygen levels.

  Recruiting University Hospital, Grenoble · La Tronche · NCT07671638

• IS M8969 safety and PK/PD in healthy and at-risk adults

  This early-phase study tests ISM8969 versus placebo to see if it is safe, well tolerated, and how the body handles and responds to it in healthy adults and obese adults at risk for heart disease.

  Recruiting Phase 1 InSilico Medicine Hong Kong Limited · Melbourne, Victoria · NCT07581431

• Ear-based vagus nerve stimulation to improve reaction time

  Researchers will try a short, noninvasive electrical stimulation of the vagus nerve at the ear to see if it shortens reaction time in healthy adults.

  Recruiting Youngstown State University · Youngstown, Ohio · NCT07528742

• Single ascending-dose safety and response test of SYH2070 injection in healthy adults

  This test gives a single subcutaneous dose of SYH2070 to healthy adults with mildly high triglycerides to see whether it is safe, how the body handles it, and whether it causes early biological effects compared with placebo.

  Recruiting Phase 1 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Shijiazhuang, Hebei · NCT07241923

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.